S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: World shares are mostly higher after S&P 500 sets another record
Mid-Cap Stocks to Outperform the Market This Cycle
Best Bear Market Funds: Top 3 Investment Options to Consider
Is DraftKings A Good Bet Ahead of Q1 Earnings?
How and When to Roll Your Options Positions?
A UK financial trader dubbed the ringleader of an interest rate manipulation scandal loses an appeal
Merck, Cintas rise; GameStop, MiMedx fall, Wednesday, 3/27/2024
S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: World shares are mostly higher after S&P 500 sets another record
Mid-Cap Stocks to Outperform the Market This Cycle
Best Bear Market Funds: Top 3 Investment Options to Consider
Is DraftKings A Good Bet Ahead of Q1 Earnings?
How and When to Roll Your Options Positions?
A UK financial trader dubbed the ringleader of an interest rate manipulation scandal loses an appeal
Merck, Cintas rise; GameStop, MiMedx fall, Wednesday, 3/27/2024
S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: World shares are mostly higher after S&P 500 sets another record
Mid-Cap Stocks to Outperform the Market This Cycle
Best Bear Market Funds: Top 3 Investment Options to Consider
Is DraftKings A Good Bet Ahead of Q1 Earnings?
How and When to Roll Your Options Positions?
A UK financial trader dubbed the ringleader of an interest rate manipulation scandal loses an appeal
Merck, Cintas rise; GameStop, MiMedx fall, Wednesday, 3/27/2024
S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: World shares are mostly higher after S&P 500 sets another record
Mid-Cap Stocks to Outperform the Market This Cycle
Best Bear Market Funds: Top 3 Investment Options to Consider
Is DraftKings A Good Bet Ahead of Q1 Earnings?
How and When to Roll Your Options Positions?
A UK financial trader dubbed the ringleader of an interest rate manipulation scandal loses an appeal
Merck, Cintas rise; GameStop, MiMedx fall, Wednesday, 3/27/2024
NASDAQ:RWLK

ReWalk Robotics (RWLK) Stock Price, News & Analysis

Today's Range
N/A
50-Day Range
$0.64
$1.25
52-Week Range
N/A
Volume
303,600 shs
Average Volume
541,468 shs
Market Capitalization
$63.04 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$3.00

ReWalk Robotics MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
∞ Upside
$3.00 Price Target
Short Interest
N/A
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.00mentions of ReWalk Robotics in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.38) to ($0.37) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.65 out of 5 stars

Medical Sector

864th out of 939 stocks

Medical Devices Industry

1st out of 1 stocks

RWLK stock logo

About ReWalk Robotics Stock (NASDAQ:RWLK)

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes robotic exoskeletons for individuals with mobility impairments or other medical conditions in the United States, Europe, the Asia-Pacific, and Africa. The company offers ReWalk Personal and ReWalk Rehabilitation for spinal cord injuries and everyday use by paraplegic individuals at home and in communities; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke in the clinical rehabilitation environment; and MyoCycle and MediTouch tutor movement biofeedback devices for use at home or in clinic. It markets and sells its products directly to third party payers; institutions, including rehabilitation centers; and individuals, as well as through third-party distributors. The company was formerly known as Argo Medical Technologies Ltd. ReWalk Robotics Ltd. was incorporated in 2001 and is headquartered in Yokneam Ilit, Israel.

RWLK Stock News Headlines

VA STAND Act introduced in the United States Senate
my top trade on these 9 tickers
This indicator is uniquely designed to spot the most significant moves in the top stocks out there (and according to our backtesting it has historically nailed these moves with a stunning 90% accuracy). Now, most folks have been saying NVDA is way overbought or overpriced. They didn’t want to “buy at the top” 6 weeks ago… Or again 4 weeks ago… or again 2 weeks ago… And it’s not their fault! That’s what all the talking heads were saying too. But the Apex Indicator would have clearly shown that these were opportunities to buy. And, sure enough, Nvidia slammed through the recommended targets again and again.
Lifeward Announces Reverse Share Split
Warning: this could blow your mind
Buckle up… ‘Cause this might shatter everything you’ve heard about “income trading”. In fact, it’s such an extreme diversion from what most people think of typical income trades that I call it: The Perfect Income Trade You see, most of the income techniques out there target a couple of percent. Maybe 5 - 10 percent if you’re lucky. But this new way of trading income on the world’s top stocks goes after more than 10x that kind of return. And here’s the best news of all: This trade can target an opportunity like that every week. Every single week. Meaning an investor has the chance to “stack up” these more aggressive income trades over and over. If that sounds interesting…
Rewalk Robotics Ltd (LFWD)
Rewalk Robotics Ltd (RWLK)
ReWalk Robotics Ltd.
ReWalk Robotics Expands Direct Sales Coverage to Canada
See More Headlines
Receive RWLK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ReWalk Robotics and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/11/2021
Today
3/27/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Medical Devices
Sub-Industry
N/A
Current Symbol
NASDAQ:RWLK
Fax
N/A
Employees
56
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$3.00
High Stock Price Target
$3.00
Low Stock Price Target
$3.00
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$-19,570,000.00
Net Margins
-238.35%
Pretax Margin
-233.51%

Debt

Sales & Book Value

Annual Sales
$5.51 million
Book Value
$1.10 per share

Miscellaneous

Free Float
58,764,000
Market Cap
$63.04 million
Optionable
Optionable
Beta
2.30
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Mr. Lawrence J. Jasinski BSMr. Lawrence J. Jasinski BS (Age 67)
    MBA, CEO & Director
    Comp: $654.03k
  • Mr. Michael A. Lawless (Age 56)
    Chief Financial Officer
    Comp: $110.24k
  • Ms. Miri Pariente (Age 47)
    Vice President of Operations, Regulatory & Quality
    Comp: $335.1k
  • Ms. Jeannine Lynch (Age 59)
    Vice President of Market Access & Strategy
    Comp: $425.98k
  • Ms. Kathleen O'Donnell
    Vice President of Marketing & New Business Development
  • Mr. Charles Remsberg
    Chief Sales Officer
  • Ms. Judy Kula
    Vice President of Customer Service, Human Resources & Business Affairs

RWLK Stock Analysis - Frequently Asked Questions

Should I buy or sell ReWalk Robotics stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for ReWalk Robotics in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" RWLK shares.
View RWLK analyst ratings
or view top-rated stocks.

What is ReWalk Robotics' stock price target for 2024?

1 equities research analysts have issued 1-year price objectives for ReWalk Robotics' shares. Their RWLK share price targets range from $3.00 to $3.00. On average, they predict the company's stock price to reach $3.00 in the next twelve months.
View analysts price targets for RWLK
or view top-rated stocks among Wall Street analysts.

How were ReWalk Robotics' earnings last quarter?

ReWalk Robotics Ltd. (NASDAQ:RWLK) issued its quarterly earnings results on Thursday, November, 11th. The medical device company reported ($0.06) earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of ($0.06). The medical device company earned $1.97 million during the quarter, compared to the consensus estimate of $1.60 million. ReWalk Robotics had a negative net margin of 238.35% and a negative trailing twelve-month return on equity of 29.00%. During the same quarter last year, the business posted ($0.18) EPS.

What other stocks do shareholders of ReWalk Robotics own?
Who are ReWalk Robotics' major shareholders?

ReWalk Robotics' stock is owned by a variety of institutional and retail investors. Top institutional investors include Kent Lake Capital LLC (1.14%), Simplex Trading LLC (0.00%) and Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include Global Fund Lp Lind II, Jeannine Lynch, Jeff Dykan, Joseph E Turk Jr, Lawrence J Jasinski and Michael A Lawless.
View institutional ownership trends
.

How do I buy shares of ReWalk Robotics?

Shares of RWLK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:RWLK) was last updated on 3/28/2024 by MarketBeat.com Staff

From Our Partners